Literature DB >> 23766244

Heterohelicenes with embedded P-chiral 1H-phosphindole or dibenzophosphole units: diastereoselective photochemical synthesis and structural characterization.

Keihann Yavari1, Pascal Retailleau, Arnaud Voituriez, Angela Marinetti.   

Abstract

The oxidative photocyclization reactions of olefins that contain 1H-phosphindole or dibenzophosphole substituents have been applied to the synthesis of P/N-bi-heterosubstituted dimeric helicenes, as well as of new [6]- and [8]phosphahelicenes. In these photocyclization processes, the configuration of the stereogenic phosphorus center dictates the sense of helical chirality. Thus, by starting from enantiomerically pure P-menthylphosphole-oxide units, this method affords enantiopure helical compounds. The helical phosphine oxides were characterized by X-ray diffraction. After reduction of the phosphine-oxides, the corresponding helical phosphines have been used as ligands in transition-metal complexes. The X-ray crystal structure of a gold chloride complex of a [6]helicene is reported.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  dibenzophospholes; enantioenriched helicenes; gold complexes; phosphahelicenes; photocyclization

Year:  2013        PMID: 23766244     DOI: 10.1002/chem.201300844

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  2 in total

1.  Phosphahelicenes: From Chiroptical and Photophysical Properties to OLED Applications.

Authors:  Keihann Yavari; Wylliam Delaunay; Nicolas De Rycke; Thibault Reynaldo; Paul Aillard; Monika Srebro-Hooper; Victoria Y Chang; Gilles Muller; Denis Tondelier; Bernard Geffroy; Arnaud Voituriez; Angela Marinetti; Muriel Hissler; Jeanne Crassous
Journal:  Chemistry       Date:  2019-03-12       Impact factor: 5.236

Review 2.  New-Generation Ligand Design for the Gold-Catalyzed Asymmetric Activation of Alkynes.

Authors:  Giuseppe Zuccarello; Imma Escofet; Ulysse Caniparoli; Antonio M Echavarren
Journal:  Chempluschem       Date:  2021-09       Impact factor: 2.863

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.